Inflammatory biomarker profile in children with cystic fibrosis: Preliminary study

Proceedings of the Nutrition Society

Volumn 69, Issue 3, 2010, Pages 354-356

  Slobodianik, N H ^a   Feliu, M S ^a   Perris, P ^a   Barbeito, S ^b   Strasnoy, I ^b   Franchello, A ^b   Ferraro, M ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

Author keywords

Biochemical parameters; Children; Cystic fibrosis; Proteins; Total antioxidant capacity

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CAROTENOID; CERULOPLASMIN; FIBRINOGEN; FLAVONOID; HAPTOGLOBIN; PREALBUMIN; TRANSFERRIN; TROLOX C;

ANTIOXIDANT ACTIVITY; CELL ASSAY; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNODIFFUSION; INFANT; INFLAMMATION; MALE; NUTRITIONAL STATUS; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCHOOL CHILD; STATISTICAL ANALYSIS; STUDENT T TEST;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CERULOPLASMIN; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HAPTOGLOBINS; HUMANS; INFANT; INFLAMMATION; MALE; NUTRITIONAL STATUS; PREALBUMIN; REFERENCE VALUES; TRANSFERRIN;

EID: 77957363364     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665110001771     Document Type: Conference Paper

References (23)

1. Rossenstein BJ & Cutting GR (1998) The diagnosis of cystic fibrosis. A consensus statement. J Pediatr 132, 589-595.
2. Nichols D, Chmiel J & Berger M (2008) Chronic inflammation in the cystic fibrosis lung: alterations in inter-and intracellular signaling. Clin Rev Allergy Immunol 4, 146-162.
3. Koletzko S & Reinhardt D (2001) Nutritional challenges of infants with cystic fibrosis. Early Hum Dev 65, S53-S61.
4. Molina Arias M, Prieto Bozano G, Sarria Oses J et al. (2001) Cystic fibrosis: nutritional considerations. An Esp Pediatr 54, 575-581.
5. Hankard R, Munck A & Navarro J (2002) Nutrition and growth in cystic fibrosis. Horm Res 58, Suppl. 1, S16-S20.
6. Anton DT, Moraru D, Cirdei E et al. (2006) Malnutrition and complex nutritional therapy in cystic fibrosis. Rev Med Chir Soc Med Nat Lasi 110, 801-806.
7. Dodge JA & Turck D (2006) Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol 20, 531-546.
8. Pencharz PB & Durie PR (2000) Pathogenesis of malnutrition in cystic fibrosis and its treatment. Clin Nutr 19, 387-394.
9. Cantin AM, White TB, Cross CE et al. (2007) Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesa, Maryland. Free Radic Biol Med 42, 15-31.
10. Lands LC, Grey VL & Grenier C (2000) Total plasma antioxidant capacity in Cystic fibrosis. Pediatr Pulmonol 29, 81-87.
11. Mancini G, Carbonara AO & Heremans GF (1965) Immunochemical quantitation of antigen by single radial immunodiffusion. Immunochemistry 2, 235-254.
12. Miller NJ, Rice-Evans CA, Davies NJ et al. (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84, 407-412.
13. Re R, Pellegrini N, Proteggente A et al. (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26, 1231-1237.
14. Feliu MS & Slobodianik NH (1992) Valores de Referencia de fracciones séricas de utilidad en estudios de nutrición, en niños. Acta Bioquím. Latinoam xxvi, 319-327.
15. Feliu MS & Slobodianik NH (1992) Valores de Referencia de fracciones séricas específicas en niños. Estudio preliminar. Bioline 6, 6-8.
16. Ingengleek Y & Young V (1994) Transthyretin (Prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 14, 495-533.
17. Perris P, Feliu MS, Barbeito S et al. (2008) Serum C3c and C4c concentrations and adenosine deaminase activity of children with cystic fibrosis: preliminary study. Proc Nutr Soc 67 (OCE), E59.
18. Emmett M, Miller JL & Crowle AJ (1987) Protein abnormalities in adult respiratory distress syndrome, tuberculosis, and cystic fibrosis sera. Proc Soc Exp Biol Med 184, 74-82.
19. Topfer G, Trefz B & Zawta B (2000) Proteins: Questions and Answers for Medical Diagnosis. Germany: Roche Diagnosis GmbH.
20. Myers G, Rifai N, Tracy R et al. (2004) CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Circulation 110, 545-549.
21. Fox PL, Mukhopadhyay C, Ehrenwal E et al. (2000) Ceruloplasmin and cardiovascular disease. Free Radic Biol Med 28, 1735-1744.
22. Rottner M, Freyssinet JM & Martínez MC (2009) Mechanisms of the noxious inflammatory cycle in cystic fibrosis. Respir Res 10, 23-34.
23. Cantin AM, White TB, Cross CE et al. (2007) Antioxidants in cystic fibrosis. Free Radic Biol Med 42, 15-31.